Scotland · NHS Scotland MSAN
H2-antagonists (cimetidine, famotidine and nizatidine) – update to MSAN
MSAN(2020)25 · issued 23 Apr 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Famotidine 20mg tablets are out of stock until 14 April 2020 (Tillomed) and May 2020 (Teva). | Out of stock | 14 April 2020 |
| Famotidine 40mg tablets are out of stock until April 2020 (Teva). | Out of stock | April 2020 |
| Cimetidine 200mg tablets are out of stock until 30 March 2020 (Ennogen) and January 2021 | Out of stock | 30 March 2020 |
| Cimetidine 400mg tablets are out of stock until 30 March 2020 (Ennogen) and 30 August 2020 | Out of stock | 30 March 2020 |
| Cimetidine 800mg tablets are out of stock until 30 March 2020 (Ennogen). | Out of stock | 30 March 2020 |
| Nizatidine 150mg and 300mg tablets are out of stock with no confirmed resupply date (Medreich | Out of stock | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.